Acute pyelonephritis in adults - Prediction of mortality and failure of treatment

被引:78
|
作者
Efstathiou, SP
Pefanis, AV
Tsioulos, DI
Zacharos, ID
Tsiakou, AG
Mitromaras, AG
Mastorantonakis, SE
Kanavaki, SN
Mountokalakis, TD
机构
[1] Univ Athens, Sch Med, Dept Med 3, Sotiria Gen Hosp, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Clin Microbiol Lab, Sotiria Gen Hosp, GR-11527 Athens, Greece
关键词
D O I
10.1001/archinte.163.10.1206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To formulate a classification tool for early recognition of patients admitted with acute pyelonephritis (AP) who are at high risk for failure of treatment or for death. Methods: A retrospective chart review of 225 patients (102 men) admitted with AP. We considered 13 potential risk factors in a multivariate analysis. Results: Recent hospitalization, previous use of antibiotics, and immunosuppression were found to be independent correlates of the prevalence of resistant pathogens in both sexes. Additional predictors included nephrolithiasis in women and a history of recurrent AP in men. Prolonged hospitalization should be expected for a man with diabetes and long-term catheterization who is older than 65 years or for a woman of any age with the same characteristics, when the initial treatment was changed according to the results of urine culture. For mortality prediction, we derived an integer-based scoring system with 6 points for shock, 4 for bedridden status, 4 for age greater than 65 years, and 3 for previous antibiotic treatment for men and 6 points for shock, 4 for bedridden status, 4 for age greater than 65 years, and 3 for immunosuppression for women. Among patients with at least 11 points, the risk for in-hospital death was 100% for men and 91% for women. Conclusions: Simple variables available at presentation can be used for risk stratification of patients with AP. The additional identification of certain risk factors by means of a carefully obtained history could contribute to early recognition of patients infected by resistant bacteria and optimize the selection of antimicrobial agents.
引用
收藏
页码:1206 / 1212
页数:7
相关论文
共 50 条
  • [1] Acute Pyelonephritis in Adults
    Spital, Aaron
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12): : 1162 - 1162
  • [2] Acute Pyelonephritis in Adults
    Johnson, James R.
    Russo, Thomas A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (01): : 48 - 59
  • [3] TREATMENT OF PYELONEPHRITIS IN ADULTS
    BERGERON, MG
    MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (03) : 619 - 649
  • [4] Acute pyelonephritis in adults: an update
    Horcajada, JP
    Smithson, A
    REVIEWS IN MEDICAL MICROBIOLOGY, 2003, 14 (04) : 119 - 127
  • [5] Prediction of mortality in acute renal failure in the tropics
    Dharan, KS
    John, GT
    Antonisamy, B
    Kirubakaran, MG
    Jacob, CK
    RENAL FAILURE, 2005, 27 (03) : 289 - 296
  • [6] Pyelonephritis and acute renal failure
    Nahar, A
    Akom, M
    Hanes, D
    Briglia, A
    Drachenberg, CB
    Weinman, EJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (02): : 121 - 123
  • [7] ACUTE-RENAL-FAILURE IN ADULTS WITH UNCOMPLICATED ACUTE PYELONEPHRITIS - CASE-REPORTS AND REVIEW
    JONES, SR
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) : 243 - 246
  • [8] Acute pyelonephritis: a cause of acute renal failure?
    Kooman, JP
    Barendregt, JNM
    van der Sande, FM
    van Suylen, RJ
    NETHERLANDS JOURNAL OF MEDICINE, 2000, 57 (05): : 185 - 189
  • [9] Diagnosis and management of acute pyelonephritis in adults
    Ramakrishnan, K
    Scheid, DC
    AMERICAN FAMILY PHYSICIAN, 2005, 71 (05) : 933 - 942
  • [10] Mortality prediction in acute heart failure: scores or biomarkers?
    Desiree, Wussler
    Eleni, Michou
    Maria, Belkin
    Nikola, Kozhuharov
    Matthias, Diebold
    Gualandro Danielle, M.
    Tobias, Breidthardt
    Christian, Mueller
    SWISS MEDICAL WEEKLY, 2020, 150